Table 1.

Baseline characteristics of patients in the intention-to-treat population.

	Control n = 180		APAD n = 180		Total n = 360
	Mean	SD	Mean	SD	Mean	SD
Age (years)	52.35	10.09	52.66	9.69	52.51	9.88
Weight (kg)	67.00	14.13	68.41	14.60	67.71	14.36
BMI (kg/m2)	25.22	5.30	25.72	5.14	25.47	5.22
BMI categories	n	%	n	%	n	%
<18.5 kg/m2	6	3.33	2	1.12	8	2.23
18.5–24.9 kg/m2	99	55.00	95	53.07	194	54.04
25–29.9 kg/m2	45	25.00	45	25.14	90	25.07
≥30 kg/m2	30	16.67	37	20.67	67	18.66
Post-menopausal	88	48.89	88	48.89	176	48.89
Tobacco smoking
Non-smoker	102	56.67	86	47.78	188	52.22
Smoker	29	16.11	34	18.89	63	17.50
Ex-smoker	49	27.22	60	33.33	109	30.28
Marital status
Single/divorced/widowed, no child	16	8.99	10	5.56	26	7.26
Single/divorced/widowed, with child	23	12.92	37	20.56	60	16.76
Married/living together, no child	21	11.80	26	14.44	47	13.13
Married/living together, with child	118	66.29	107	59.44	225	62.85
Education level
No qualifications	29	16.57	24	13.56	53	15.06
Secondary level	43	24.57	31	17.51	74	21.02
Completed high school	29	16.57	43	24.29	72	20.45
Completed ≥ 2 years at university	74	42.29	79	44.64	153	43.47
Usual professional status
Full or part-time employed	97	53.89	103	57.22	200	55.56
Retired	42	23.33	41	22.78	83	23.06
Unemployed/medical leave	41	22.78	36	20.00	77	21.38
EPICES precariousness (or deprivation) level
Non-precarious	109	60.56	109	60.56	218	60.56
Intermediate	60	33.33	60	33.33	120	33.33
Precarious	11	6.11	11	6.11	22	6.11
Surgery type	n	%	n	%	n	%
Lumpectomy	89	49.44	88	48.89	177	49.17
Quadrantectomy	37	20.56	45	25.00	82	22.78
Mastectomy	54	30.00	46	25.56	100	27.78
T stage
T1	91	50.56	97	53.89	188	52.22
T2	74	41.11	73	40.56	147	40.83
T3	11	6.11	8	4.44	19	5.28
T3	3	1.67	1	0.56	4	1.11
T4	1	0.56	0	0	1	0.28
Tis	0	0	1	0.56	1	0.28
T stage
N0	71	39.66	79	44.63	150	42.13
N1	86	48.04	83	46.89	169	47.47
N2	14	7.82	11	6.21	25	7.02
N3	7	3.91	3	1.69	10	2.81
NX	1	0.56	1	0.56	2	0.56
Breast cancer subtype
Triple negative	17	18.48	17	18.89	34	18.68
HER2+, ER+, and/or PR+	29	31.52	35	38.89	64	35.16
HER2+, ER−, and PR−	9	9.78	10	11.11	19	10.44
HER2−, ER+, and/or PR+	37	40.22	28	31.11	65	35.71